Kourie Joseph I
Membrane Transport Group, Department of Chemistry, The Faculties, Building 33, Science Road, The Australian National University, Canberra City, ACT 0200, Australia.
Eur Biophys J. 2002 Sep;31(5):409-16. doi: 10.1007/s00249-002-0242-2. Epub 2002 Jul 23.
The prion encephalopathies, which are characterized by neuropathological changes that include vacuolation, astrocytosis, the development of amyloid plaques and neuronal loss, are associated with the conversion of a normal cellular isoform of prion protein (PrP(c)) to an abnormal pathologic scrapie isoform (PrP(Sc)). The use of PrP[106-126] and its isoforms in studies of channels in lipid bilayers has revealed that it forms heterogeneous channels reflecting modifications in the peptide's structure and differences in the properties of the formed oligomeric aggregates and their intermediates. We propose that the accumulation of pathological isoforms of prion are linked to membrane abnormalities and vacuolation in prion diseases. The interlinked changes in membrane fluidity and endogenous channels induced by prion isoforms can occur independently and concurrently with channel formation, i.e. they are not mutually exclusive. We suggest that vacuolation is a cellular response triggered in order to immobilize pathological prion isoforms having the ability to form channels that compromise cellular membranes. This mechanism is similar to that of other channel-forming proteins that induce vacuolation, e.g. the well-established VacA of Helicobacter pylori, Vero cells and aerolysin, as well as melittin-induced micellization and membrane fusion. We conclude that channel formation is part of the molecular mechanisms responsible for the vacuolation associated with prion diseases. The initial vacuolation could be an adaptive cellular response to compartmentalize the increase in pathogenic prion isoforms, while an excessive accumulation of pathologic prion isoforms in later stages represents the inability of the cell to continue to compartmentalize these misfolded proteins in vacuoles.
朊病毒脑病的特征是神经病理学变化,包括空泡化、星形细胞增生、淀粉样斑块的形成和神经元丧失,它与正常细胞形式的朊病毒蛋白(PrP(c))转化为异常病理瘙痒病形式(PrP(Sc))有关。在脂质双层通道研究中使用PrP[106 - 126]及其异构体表明,它形成了异质性通道,反映了肽结构的修饰以及所形成的寡聚聚集体及其中间体性质的差异。我们提出,朊病毒病理异构体的积累与朊病毒疾病中的膜异常和空泡化有关。朊病毒异构体引起的膜流动性和内源性通道的相互关联变化可以独立发生,也可以与通道形成同时发生,即它们并非相互排斥。我们认为,空泡化是一种细胞反应,旨在固定具有形成损害细胞膜通道能力的病理性朊病毒异构体。这种机制类似于其他诱导空泡化的成孔蛋白,例如幽门螺杆菌的成熟VacA、Vero细胞和气溶素,以及蜂毒肽诱导的胶束化和膜融合。我们得出结论,通道形成是与朊病毒疾病相关的空泡化分子机制的一部分。最初的空泡化可能是一种适应性细胞反应,用于分隔致病性朊病毒异构体的增加,而后期病理性朊病毒异构体的过度积累则代表细胞无法继续将这些错误折叠的蛋白质分隔在液泡中。